162 related articles for article (PubMed ID: 28606845)
1. Effects of Community Screening for Helicobacter pylori: 13-Year Follow-Up Evaluation of a Randomized Controlled Trial.
Bomme M; Hansen JM; Wildner-Christensen M; Hallas J; Schaffalitzky de Muckadell OB
Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1715-1723.e7. PubMed ID: 28606845
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
Mason J; Axon AT; Forman D; Duffett S; Drummond M; Crocombe W; Feltbower R; Mason S; Brown J; Moayyedi P;
Aliment Pharmacol Ther; 2002 Mar; 16(3):559-68. PubMed ID: 11876711
[TBL] [Abstract][Full Text] [Related]
3. Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
Hansen JM; Wildner-Christensen M; Hallas J; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2008 May; 103(5):1106-13. PubMed ID: 18445098
[TBL] [Abstract][Full Text] [Related]
4. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
Lane JA; Murray LJ; Noble S; Egger M; Harvey IM; Donovan JL; Nair P; Harvey RF
BMJ; 2006 Jan; 332(7535):199-204. PubMed ID: 16428249
[TBL] [Abstract][Full Text] [Related]
5. The cost effectiveness of Helicobacter pylori population screening-economic evaluation alongside a randomised controlled trial with 13-year follow-up.
Høgh MB; Kronborg C; Hansen JM; Schaffalitzky de Muckadell OB
Aliment Pharmacol Ther; 2019 Apr; 49(8):1013-1025. PubMed ID: 30854700
[TBL] [Abstract][Full Text] [Related]
6. A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial.
Ford AC; Forman D; Bailey AG; Axon AT; Moayyedi P
Gastroenterology; 2005 Dec; 129(6):1910-7. PubMed ID: 16344059
[TBL] [Abstract][Full Text] [Related]
7. Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population.
Wildner-Christensen M; Møller Hansen J; Schaffalitzky De Muckadell OB
Gastroenterology; 2003 Aug; 125(2):372-9. PubMed ID: 12891538
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori and non-malignant upper gastrointestinal diseases.
Vasapolli R; Malfertheiner P; Kandulski A
Helicobacter; 2016 Sep; 21 Suppl 1():30-3. PubMed ID: 27531536
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project.
Harvey RF; Lane JA; Nair P; Egger M; Harvey I; Donovan J; Murray L
Aliment Pharmacol Ther; 2010 Aug; 32(3):394-400. PubMed ID: 20491744
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation.
Roderick P; Davies R; Raftery J; Crabbe D; Pearce R; Patel P; Bhandari P
J Med Screen; 2003; 10(3):148-56. PubMed ID: 14561268
[TBL] [Abstract][Full Text] [Related]
11. [Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].
Schilling D; Messerer P; Ott MG; Schauwecker P; Zober A; Riemann JF
Med Klin (Munich); 2002 Jan; 97(1):6-11. PubMed ID: 11831064
[TBL] [Abstract][Full Text] [Related]
12. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
Sonnenberg A
Am J Gastroenterol; 1996 Sep; 91(9):1773-7. PubMed ID: 8792696
[TBL] [Abstract][Full Text] [Related]
13. Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication--a 7-year follow-up study.
Maconi G; Sainaghi M; Molteni M; Bosani M; Gallus S; Ricci G; Alvisi V; Porro GB
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):387-93. PubMed ID: 19182682
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.
Allison JE; Hurley LB; Hiatt RA; Levin TR; Ackerson LM; Lieu TA
Arch Intern Med; 2003 May; 163(10):1165-71. PubMed ID: 12767952
[TBL] [Abstract][Full Text] [Related]
15. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
[TBL] [Abstract][Full Text] [Related]
16. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
[TBL] [Abstract][Full Text] [Related]
17. Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community.
Sone Y; Kumada T; Toyoda H; Yokoyama M; Kato M; Asaka M
Helicobacter; 2008 Oct; 13(5):346-51. PubMed ID: 19250509
[TBL] [Abstract][Full Text] [Related]
18. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of Helicobacter pylori infection and the affecting factors: A follow-up study.
Zhou LY; Song ZQ; Xue Y; Li X; Li YQ; Qian JM
J Dig Dis; 2017 Jan; 18(1):47-55. PubMed ID: 28026906
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases.
Chen Q; Liang X; Long X; Yu L; Liu W; Lu H
Helicobacter; 2019 Apr; 24(2):e12563. PubMed ID: 30672082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
